154 related articles for article (PubMed ID: 25106135)
1. Biologic comparison of inhaled insulin formulations: Exubera™ and novel spray-dried engineered particles of dextran-10.
Kuehl PJ; Cherrington A; Dobry DE; Edgerton D; Friesen DT; Hobbs C; Leach CL; Murri B; Neal D; Lyon DK; Vodak DT; Reed MD
AAPS PharmSciTech; 2014 Dec; 15(6):1545-50. PubMed ID: 25106135
[TBL] [Abstract][Full Text] [Related]
2. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
You Y; Zhao M; Liu G; Tang X
J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
[TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of insulin dry powder for inhalation.
Mahesh Kumar T; Misra A
Drug Dev Ind Pharm; 2006 Jul; 32(6):677-86. PubMed ID: 16885123
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
Razavi Rohani SS; Abnous K; Tafaghodi M
Int J Pharm; 2014 Apr; 465(1-2):464-78. PubMed ID: 24560646
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of inhalable spore like pharmaceutical particles for deep lung deposition.
Shen ZG; Chen WH; Jugade N; Gao LY; Glover W; Shen JY; Yun J; Chen JF
Int J Pharm; 2012 Jul; 430(1-2):98-103. PubMed ID: 22486960
[TBL] [Abstract][Full Text] [Related]
6. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles.
Chalasani KB; Russell-Jones GJ; Jain AK; Diwan PV; Jain SK
J Control Release; 2007 Sep; 122(2):141-50. PubMed ID: 17707540
[TBL] [Abstract][Full Text] [Related]
7. Insulin-micro- and nanoparticles for pulmonary delivery.
Klingler C; Müller BW; Steckel H
Int J Pharm; 2009 Jul; 377(1-2):173-9. PubMed ID: 19446621
[TBL] [Abstract][Full Text] [Related]
8. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
[TBL] [Abstract][Full Text] [Related]
9. Effect of additives on insulin absorption from intratracheally administered dry powders in rats.
Todo H; Okamoto H; Iida K; Danjo K
Int J Pharm; 2001 Jun; 220(1-2):101-10. PubMed ID: 11376972
[TBL] [Abstract][Full Text] [Related]
10. The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation.
Ståhl K; Claesson M; Lilliehorn P; Lindén H; Bäckström K
Int J Pharm; 2002 Feb; 233(1-2):227-37. PubMed ID: 11897427
[TBL] [Abstract][Full Text] [Related]
11. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
[TBL] [Abstract][Full Text] [Related]
12. Influence of deposition and spray pattern of nasal powders on insulin bioavailability.
Pringels E; Callens C; Vervaet C; Dumont F; Slegers G; Foreman P; Remon JP
Int J Pharm; 2006 Mar; 310(1-2):1-7. PubMed ID: 16427222
[TBL] [Abstract][Full Text] [Related]
13. Pure insulin highly respirable powders for inhalation.
Balducci AG; Cagnani S; Sonvico F; Rossi A; Barata P; Colombo G; Colombo P; Buttini F
Eur J Pharm Sci; 2014 Jan; 51():110-7. PubMed ID: 23981336
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery.
Li X; Mansour HM
AAPS PharmSciTech; 2011 Dec; 12(4):1420-30. PubMed ID: 22038473
[TBL] [Abstract][Full Text] [Related]
15. Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles.
Weers JG; Miller DP; Tarara TE
AAPS PharmSciTech; 2019 Feb; 20(3):103. PubMed ID: 30734187
[TBL] [Abstract][Full Text] [Related]
16. [Distribution of surface components in spray-dried powder of binary system of berberine hydrochloride and dextran based on hydrodynamic size].
Han XX; Meng ZP; Chen XY; Deng XM; Liang YM; Ma XA; Xie JJ; Fu TM
Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3224-3232. PubMed ID: 35851115
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of pulmonary insulin delivery in diabetic rats: use of a model-based approach in the evaluation of insulin powder formulations.
Amidi M; Krudys KM; Snel CJ; Crommelin DJ; Della Pasqua OE; Hennink WE; Jiskoot W
J Control Release; 2008 May; 127(3):257-66. PubMed ID: 18353483
[TBL] [Abstract][Full Text] [Related]
18. Design of spray dried insulin microparticles to bypass deposition in the extrathoracic region and maximize total lung dose.
Ung KT; Rao N; Weers JG; Huang D; Chan HK
Int J Pharm; 2016 Sep; 511(2):1070-9. PubMed ID: 27480399
[TBL] [Abstract][Full Text] [Related]
19. Development of porous particles using dextran as an excipient for enhanced deep lung delivery of rifampicin.
Kadota K; Yanagawa Y; Tachikawa T; Deki Y; Uchiyama H; Shirakawa Y; Tozuka Y
Int J Pharm; 2019 Jan; 555():280-290. PubMed ID: 30471373
[TBL] [Abstract][Full Text] [Related]
20. Formulation and in vitro evaluation of highly dispersive insulin dry powder formulations for lung administration.
Depreter F; Amighi K
Eur J Pharm Biopharm; 2010 Nov; 76(3):454-63. PubMed ID: 20797437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
